{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:29Z","timestamp":1790117249541,"version":"4.0.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10753-021-01589-7","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:06:31Z","timestamp":1637132791000},"page":"477-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["AGE\/Non-AGE Glycation: An Important Event in Rheumatoid Arthritis Pathophysiology"],"prefix":"10.1007","volume":"45","author":[{"family":"Monu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Agnihotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2017-1670","authenticated-orcid":false,"given":"Sagarika","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"15","key":"1589_CR1","first-page":"1","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo, Q., Y. Wang, D. Xu, J. Nossent, N.J. Pavlos, and J. Xu. 2018. Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Research 6 (15): 1\u201314.","journal-title":"Bone Research"},{"key":"1589_CR2","unstructured":"WHO. 2018. Rheumatoid Arthritis. www.who.int\/chp\/topics\/rheumatic\/en\/"},{"issue":"9","key":"1589_CR3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M. Hazes, K. Hobbs, T.W. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. M\u00e9nard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsk\u00fd, F. Wolfe, and G. Hawker. 2010. Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatology 62 (9): 2569\u20132581.","journal-title":"Arthritis Rheumatology"},{"issue":"18001","key":"1589_CR4","first-page":"1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J.S., D. Aletaha, A. Barton, G.R. Burmester, P. Emery, G.S. Firestein, A. Kavanaugh, I.B. McInnes, D.H. Solomon, V. Strand, and K. Yamamoto. 2018. Rheumatoid arthritis. Nature Reviews Disease Primers 4 (18001): 1\u201323.","journal-title":"Nature Reviews Disease Primers"},{"issue":"6363086","key":"1589_CR5","first-page":"22","volume":"2019","author":"Q Fang","year":"2019","unstructured":"Fang, Q., and O, Jiaxin, and K.S. Nandakumar. 2019. Autoantibodies as diagnostic markers and mediator of joint inflammation in arthritis. Mediators of Inflammation 2019 (6363086): 22.","journal-title":"Mediators of Inflammation"},{"issue":"657","key":"1589_CR6","first-page":"1","volume":"8","author":"F Carubbi","year":"2019","unstructured":"Carubbi, F., A. Alunno, R. Gerli, and R. Giacomelli. 2019. Post-translational modifications of proteins: Novel insights in the autoimmune response in rheumatoid arthritis. Cells 8 (657): 1\u201313.","journal-title":"Cells"},{"key":"1589_CR7","doi-asserted-by":"crossref","first-page":"5716409","DOI":"10.1155\/2017\/5716409","volume":"2017","author":"AL Santos","year":"2017","unstructured":"Santos, A.L., and A.B. Lindner. 2017. Protein post translational modifications: Roles in aging and age-related disease. Oxidative Medicine and Cellular Longevity 2017: 5716409.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1589_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nchembio.2575","volume":"14","author":"R Harmel","year":"2018","unstructured":"Harmel, R., and D. Fiedler. 2018. Features and regulation of non-enzymatic post-translational modifications. Nature Chemical Biology 14: 244\u2013252.","journal-title":"Nature Chemical Biology"},{"issue":"6","key":"1589_CR9","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1186\/ar3538","volume":"13","author":"L DeGroot","year":"2011","unstructured":"DeGroot, L., H. Hinkema, J. Westra, A.J. Smit, C.G. Kallenberg, M. Bijl, and M.D. Posthumus. 2011. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Research & Therapy 13 (6): R205.","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"1589_CR10","first-page":"50","volume":"4","author":"NA Ansari","year":"2013","unstructured":"Ansari, N.A., and D. Dash. 2013. Amadori glycated proteins: Role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging and Disease 4 (1): 50\u201356.","journal-title":"Aging and Disease"},{"issue":"8","key":"1589_CR11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dc15-2727","volume":"39","author":"KJ Welsh","year":"2016","unstructured":"Welsh, K.J., M.S. Kirkman, and D.B. Sacks. 2016. Role of glycated proteins in the diagnosis and management of diabetes: Research gaps and future directions. Diabetes Care 39 (8): 1299\u20131306.","journal-title":"Diabetes Care"},{"issue":"3","key":"1589_CR12","first-page":"154","volume":"36","author":"P Younessi","year":"2011","unstructured":"Younessi, P., and A. Yoonessi. 2011. Advanced glycation end-products and their receptor-mediated roles: Inflammation and oxidative stress. The Iranian Journal of Medical Sciences 36 (3): 154\u2013166.","journal-title":"The Iranian Journal of Medical Sciences"},{"issue":"12","key":"1589_CR13","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1007\/s13197-015-1851-y","volume":"52","author":"C Sharma","year":"2015","unstructured":"Sharma, C., A. Kaur, S.S. Thind, B. Singh, and S. Raina. 2015. Advanced glycation end-products (AGEs): An emerging concern for processed food industries. The Journal of Food Science and Technology 52 (12): 7561\u20137576.","journal-title":"The Journal of Food Science and Technology"},{"key":"1589_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.fct.2013.06.052","volume":"60","author":"MW Poulsen","year":"2013","unstructured":"Poulsen, M.W., R.V. Hedegaard, J.M. Andersen, B. de Courten, S. B\u00fcgel, J. Nielsen, L.H. Skibsted, and L.O. Dragsted. 2013. Advanced glycation endproducts in food and their effects on health. Food and chemical toxicology: An international journal published for the British Industrial Biological Research Association 60: 10\u201337.","journal-title":"Food and chemical toxicology: An international journal published for the British Industrial Biological Research Association"},{"issue":"2","key":"1589_CR15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/pr800858h","volume":"8","author":"Q Zhang","year":"2009","unstructured":"Zhang, Q., J.M. Ames, R.D. Smith, J.W. Baynes, and T.O. Metz. 2009. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: Probing the pathogenesis of chronic disease. Journal of Proteome Research 8 (2): 754\u2013769.","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"1589_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"VP Singh","year":"2014","unstructured":"Singh, V.P., A. Bali, N. Singh, and A.S. Jaggi. 2014. Advanced glycation end products and diabetic complications. The Korean Journal of Physiology & Pharmacology 18 (1): 1\u201314.","journal-title":"The Korean Journal of Physiology & Pharmacology"},{"issue":"41","key":"1589_CR17","doi-asserted-by":"crossref","first-page":"28676","DOI":"10.1074\/jbc.M114.563593","volume":"289","author":"C Henning","year":"2014","unstructured":"Henning, C., K. Liehr, M. Girndt, C. Ulrich, and M.A. Glomb. 2014. Extending the spectrum of \u03b1-dicarbonyl compounds in vivo. The Journal of biological chemistry 289 (41): 28676\u201328688.","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"1589_CR18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/ijms18050984","volume":"18","author":"S Brings","year":"2017","unstructured":"Brings, S., T. Fleming, M. Freichel, M.U. Muckenthaler, S. Herzig, and P.P. Nawroth. 2017. Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention. International Journal of Molecular Sciences 18 (5): 984.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"1589_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/DMDI.2008.23.1-2.125","volume":"23","author":"PJ Thornalley","year":"2008","unstructured":"Thornalley, P.J. 2008. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems\u2013role in ageing and disease. Drug Metabolism and Drug Interactions 23 (1\u20132): 125\u2013150.","journal-title":"Drug Metabolism and Drug Interactions"},{"issue":"12","key":"1589_CR20","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.bbadis.2018.08.036","volume":"1864","author":"S Rowan","year":"2018","unstructured":"Rowan, S., E. Bejarano, and A. Taylor. 2018. Mechanistic targeting of advanced glycation end-products in age-related diseases. Biochimica et biophysica acta Molecular basis of disease 1864 (12): 3631\u20133643.","journal-title":"Biochimica et biophysica acta Molecular basis of disease"},{"issue":"1","key":"1589_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo, T., D. Zhang, Y. Zeng, T.Y. Huang, H. Xu, and Y. Zhao. 2020. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Molecular neurodegeneration 15 (1): 40.","journal-title":"Molecular neurodegeneration"},{"issue":"3","key":"1589_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri, J., Y. Bains, S. Guha, A. Kahn, D. Hall, N. Bose, A. Gugliucci, and P. Kapahi. 2018. The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality. Cell Metabolism 28 (3): 337\u2013352.","journal-title":"Cell Metabolism"},{"issue":"1","key":"1589_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"Fishman, S.L., H. Sonmez, C. Basman, V. Singh, and L. Poretsky. 2018. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: A review. Molecular Medicine 24 (1): 59.","journal-title":"Molecular Medicine"},{"key":"1589_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Otta","year":"2014","unstructured":"Otta, C., K. Jacobsb, E. Hauckec, A.N. Santos, T. Grunea, and A. Simm. 2014. Role of advanced glycation end products in cellular signalling. Redox Biology 2: 411\u2013429.","journal-title":"Redox Biology"},{"key":"1589_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmolb.2014.00009","volume":"1","author":"C Iannuzzi","year":"2014","unstructured":"Iannuzzi, C., G. Irace, and I. Sirangelo. 2014. Differential effects of glycation on protein aggregation and amyloid formation. Frontiers in Molecular Biosciences 1: 9.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"1589_CR26","doi-asserted-by":"crossref","first-page":"6097417","DOI":"10.1155\/2016\/6097417","volume":"2016","author":"CM Qui\u00f1onez-Flores","year":"2016","unstructured":"Qui\u00f1onez-Flores, C.M., S.A. Gonz\u00e1lez-Ch\u00e1vez, D. Del R\u00edo N\u00e1jera, and C. Pacheco-Tena. 2016. Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: A systematic review. BioMed Research International 2016: 6097417.","journal-title":"BioMed Research International"},{"issue":"1","key":"1589_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","volume":"30","author":"A Phaniendra","year":"2015","unstructured":"Phaniendra, A., D.B. Jestadi, and L. Periyasamy. 2015. Free radicals: Properties sources targets and their implication in various diseases. Indian journal of clinical biochemistry 30 (1): 11\u201326.","journal-title":"Indian journal of clinical biochemistry"},{"issue":"3","key":"1589_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.2008.03634.x","volume":"152","author":"LI Filippin","year":"2008","unstructured":"Filippin, L.I., R. Vercelino, N.P. Marroni, and R.M. Xavier. 2008. Redox signalling and the inflammatory response in rheumatoid arthritis. Clinical and experimental immunology 152 (3): 415\u2013422.","journal-title":"Clinical and experimental immunology"},{"key":"1589_CR29","first-page":"7536805","volume":"2019","author":"L da Fonseca","year":"2019","unstructured":"da Fonseca, L., V. Nunes-Souza, M. Goulart, and L.A. Rabelo. 2019. Oxidative stress in rheumatoid arthritis: What the future might hold regarding novel biomarkers and add-on therapies. Oxidative medicine and cellular longevity 2019: 7536805.","journal-title":"Oxidative medicine and cellular longevity"},{"key":"1589_CR30","doi-asserted-by":"crossref","unstructured":"Wright, H. L., M. Lyon, E.A. Chapman, R.J. Moots, and S.W. Edwards. 2021. Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines reactive oxygen species and neutrophil extracellular traps. Frontiers in immunology 11: 584116.","DOI":"10.3389\/fimmu.2020.584116"},{"issue":"4","key":"1589_CR31","first-page":"457","volume":"41","author":"TA Butterfield","year":"2006","unstructured":"Butterfield, T.A., T.M. Best, and M.A. Merrick. 2006. The dual roles of neutrophils and macrophages in inflammation: A critical balance between tissue damage and repair. Journal of athletic training 41 (4): 457\u2013465.","journal-title":"Journal of athletic training"},{"issue":"1","key":"1589_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/rb\/rbw041","volume":"4","author":"GS Selders","year":"2017","unstructured":"Selders, G.S., A.E. Fetz, M.Z. Radic, and G.L. Bowlin. 2017. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration. Regenerative biomaterials 4 (1): 55\u201368.","journal-title":"Regenerative biomaterials"},{"key":"1589_CR33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","volume":"8","author":"V Delgado-Rizo","year":"2017","unstructured":"Delgado-Rizo, V., M.A. Mart\u00ednez-Guzm\u00e1n, L. I\u00f1iguez-Gutierrez, A. Garc\u00eda-Orozco, A. Alvarado-Navarro, and M. Fafutis-Morris. 2017. Neutrophil extracellular traps and its implications in inflammation: An overview. Frontiers in Immunology 8: 81.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"1589_CR34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cells9040915","volume":"9","author":"E Fousert","year":"2020","unstructured":"Fousert, E., R. Toes, and J. Desai. 2020. Neutrophil Extracellular Traps (NETs) Take the central stage in driving autoimmune responses. Cells 9 (4): 915.","journal-title":"Cells"},{"issue":"10","key":"1589_CR35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1134\/S0006297920100065","volume":"85","author":"NV Vorobjeva","year":"2020","unstructured":"Vorobjeva, N.V., and B.V. Chernyak. 2020. NETosis: Molecular mechanisms role in physiology and pathology. Biochemistry Biokhimiia 85 (10): 1178\u20131190.","journal-title":"Biochemistry Biokhimiia"},{"issue":"3","key":"1589_CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","volume":"8","author":"KD Metzler","year":"2014","unstructured":"Metzler, K.D., C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos. 2014. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Reports 8 (3): 883\u2013896.","journal-title":"Cell Reports"},{"issue":"3","key":"1589_CR37","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Sur Chowdhury","year":"2014","unstructured":"Sur Chowdhury, C., S. Giaglis, U.A. Walker, A. Buser, S. Hahn, and P. Hasler. 2014. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: Analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis research & therapy 16 (3): R122.","journal-title":"Arthritis research & therapy"},{"key":"1589_CR38","doi-asserted-by":"crossref","unstructured":"Heidari, F., S. Rabizadeh, A. Rajab, F. Heidari, M. Mouodi, H. Mirmiranpour, A. Esteghamati, and M. Nakhjavani. 2020. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes. Life sciences 260: 118422.","DOI":"10.1016\/j.lfs.2020.118422"},{"key":"1589_CR39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.freeradbiomed.2016.06.020","volume":"97","author":"HM Khojah","year":"2016","unstructured":"Khojah, H.M., S. Ahmed, M.S. Abdel-Rahman, and A.B. Hamza. 2016. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants. Free radical biology & medicine 97: 285\u2013291.","journal-title":"Free radical biology & medicine"},{"issue":"6","key":"1589_CR40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/07853890902806576","volume":"41","author":"SF Yan","year":"2009","unstructured":"Yan, S.F., S.D. Yan, R. Ramasamy, and A.M. Schmidt. 2009. Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications neurodegeneration and inflammation. Annals of Medicine 41 (6): 408\u2013422.","journal-title":"Annals of Medicine"},{"issue":"5","key":"1589_CR41","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.str.2011.02.013","volume":"19","author":"J Xue","year":"2011","unstructured":"Xue, J., V. Rai, D. Singer, S. Chabierski, J. Xie, S. Reverdatto, D.S. Burz, A.M. Schmidt, R. Hoffmann, and A. Shekhtman. 2011. Advanced glycation end product recognition by the receptor for AGEs. Structure 19 (5): 722\u2013732.","journal-title":"Structure"},{"key":"1589_CR42","doi-asserted-by":"publisher","first-page":"6556","DOI":"10.1111\/febs.12556","volume":"280","author":"L Yatime","year":"2013","unstructured":"Yatime, L., and G.R. Andersen. 2013. Structural insights into the oligomerization mode of the human Receptor for Advanced Glycation End-products (RAGE). The FEBS journal 280: 6556\u20136568. https:\/\/doi.org\/10.1111\/febs.12556.","journal-title":"The FEBS journal"},{"key":"1589_CR43","doi-asserted-by":"crossref","unstructured":"Chuah, Y.K., R. Basir, H. Talib, T.H. Tie, and N. Nordin. 2013. Receptor for advanced glycation end products and its involvement in inflammatory diseases. International Journal of Inflammation 2013: 403460.","DOI":"10.1155\/2013\/403460"},{"key":"1589_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.594622","volume":"7","author":"M Nadali","year":"2021","unstructured":"Nadali, M., L. Lyngfelt, M.C. Erlandsson, S.T. Silfversward, K.M.E. Andersson, M.I. Bokarewa, and T. Pullerits. 2021. Low soluble receptor for advanced glycation end products precedes and predicts cardiometabolic events in women with rheumatoid arthritis. Frontiers in Medicine 7: 594622. https:\/\/doi.org\/10.3389\/fmed.2020.594622.","journal-title":"Frontiers in Medicine"},{"key":"1589_CR45","doi-asserted-by":"crossref","first-page":"3818196","DOI":"10.1155\/2020\/3818196","volume":"2020","author":"A Perrone","year":"2020","unstructured":"Perrone, A., A. Giovino, J. Benny, and F. Martinelli. 2020. Advanced glycation end products (AGEs): Biochemistry signaling analytical methods and epigenetic effects. Oxidative medicine and cellular longevity 2020: 3818196.","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"10","key":"1589_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells7100161","volume":"7","author":"HY Yap","year":"2018","unstructured":"Yap, H.Y., S.Z. Tee, M.M. Wong, S.K. Chow, S.C. Peh, and S.Y. Teow. 2018. Pathogenic role of immune cells in rheumatoid arthritis: Implications in clinical treatment and biomarker development. Cells 7 (10): 161.","journal-title":"Cells"},{"issue":"5","key":"1589_CR47","first-page":"2169","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen, J., J. Jing, S. Yu, M. Song, H. Tan, B. Cui, and L. Huang. 2016. Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase\/JNK signaling axis. American journal of translational research 8 (5): 2169\u20132178.","journal-title":"American journal of translational research"},{"issue":"12","key":"1589_CR48","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/ijms19123824","volume":"19","author":"A Tarafdar","year":"2018","unstructured":"Tarafdar, A., and G. Pula. 2018. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. International journal of molecular sciences 19 (12): 3824.","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"1589_CR49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11626-014-9823-5","volume":"51","author":"X Wang","year":"2015","unstructured":"Wang, X., S. Yu, C.Y. Wang, Y. Wang, H.X. Liu, Y. Cui, and L.D. Zhang. 2015. Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells. In vitro cellular & developmental biology-Animal 51 (2): 204\u2013209.","journal-title":"In vitro cellular & developmental biology-Animal"},{"issue":"11","key":"1589_CR50","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/molecules25112555","volume":"25","author":"I P\u00e9rez-Torres","year":"2020","unstructured":"P\u00e9rez-Torres, I., L. Manzano-Pech, M.E. Rubio-Ru\u00edz, M.E. Soto, and V. Guarner-Lans. 2020. Nitrosative stress and its association with cardiometabolic disorders. Molecules (Basel, Switzerland) 25 (11): 2555.","journal-title":"Molecules (Basel, Switzerland)"},{"key":"1589_CR51","first-page":"18","volume":"2020","author":"A Giovino","year":"2020","unstructured":"Giovino, A., J. Benny, and F. Martinelli. 2020. Advanced glycation end products (AGEs): Biochemistry, signaling, analytical methods, and epigenetic effects. Oxidative Medicine and Cellular Longevity 2020: 18.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1589_CR52","doi-asserted-by":"crossref","unstructured":"Semchyshyn, H.M. 2014. Reactive carbonyl species in vivo: generation and dual biological effects. The Scientific World Journal 2014: 417842.","DOI":"10.1155\/2014\/417842"},{"key":"1589_CR53","doi-asserted-by":"crossref","first-page":"9574201","DOI":"10.1155\/2017\/9574201","volume":"2017","author":"F Hansen","year":"2017","unstructured":"Hansen, F., F. Galland, F. Lirio, D.F. de Souza, C. Da R\u00e9, R.F. Pacheco, A.F. Vizuete, A. Quincozes-Santos, M.C. Leite, and C.A. Gon\u00e7alves. 2017. Methylglyoxal induces changes in the glyoxalase system and impairs glutamate uptake activity in primary astrocytes. Oxidative medicine and cellular longevity 2017: 9574201.","journal-title":"Oxidative medicine and cellular longevity"},{"key":"1589_CR54","doi-asserted-by":"crossref","first-page":"8735926","DOI":"10.1155\/2018\/8735926","volume":"2018","author":"I Knani","year":"2018","unstructured":"Knani, I., H. Bouzidi, S. Zrour, N. Bergaoui, M. Hammami, and M. Kerkeni. 2018. Methylglyoxal: A relevant marker of disease activity in patients with rheumatoid arthritis. Disease Markers 2018: 8735926.","journal-title":"Disease Markers"},{"issue":"1","key":"1589_CR55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk, C.G., and C. Stehouwer. 2020. Methylglyoxal a highly reactive dicarbonyl compound in diabetes its vascular complications and other age-related diseases. Physiological reviews 100 (1): 407\u2013461.","journal-title":"Physiological reviews"},{"issue":"15","key":"1589_CR56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1556\/OH.2012.29348","volume":"153","author":"Z Kender","year":"2012","unstructured":"Kender, Z., P. Torzsa, K.V. Grolmusz, A. Pat\u00f3cs, A. Lichthammer, M. Veresn\u00e9 B\u00e1lint, K. R\u00e1cz, and P. Reismann. 2012. A metilgliox\u00e1l metabolizmus szerepe 2-es t\u00edpus\u00fa cukorbetegs\u00e9gben \u00e9s sz\u00f6v\u0151dm\u00e9nyeiben [The role of methylglyoxal metabolism in type-2 diabetes and its complications]. Orvosi hetilap 153 (15): 574\u2013585.","journal-title":"Orvosi hetilap"},{"issue":"4","key":"1589_CR57","doi-asserted-by":"crossref","first-page":"R817","DOI":"10.1186\/ar1749","volume":"7","author":"R Pullerits","year":"2005","unstructured":"Pullerits, R., M. Bokarewa, L. Dahlberg, and A. Tarkowski. 2005. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Research Therapy 7 (4): R817\u2013R824.","journal-title":"Arthritis Research Therapy"},{"issue":"4","key":"1589_CR58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1479164111416831","volume":"8","author":"T Lund","year":"2011","unstructured":"Lund, T., A. Svindland, M. Pepaj, A.B. Jensen, J.P. Berg, B. Kilhovd, and K.F. Hanssen. 2011. Fibrinogen may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diabetes & vascular disease research 8 (4): 284\u2013294.","journal-title":"Diabetes & vascular disease research"},{"key":"1589_CR59","first-page":"129","volume":"186","author":"JN Shaw","year":"2002","unstructured":"Shaw, J.N., J.W. Baynes, and S.R. Thorpe. 2002. N epsilon-(carboxymethyl) lysine (CML) as a biomarker of oxidative stress in long-lived tissue proteins. Methods in Molecular Biology 186: 129\u2013137.","journal-title":"Methods in Molecular Biology"},{"issue":"6","key":"1589_CR60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.61.6.488","volume":"61","author":"S Drinda","year":"2002","unstructured":"Drinda, S., S. Franke, C.C. Canet, P. Petrow, R. Br\u00e4uer, C. H\u00fcttich, G. Stein, and G. Hein. 2002. Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 61 (6): 488\u2013492.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"1589_CR61","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0004563217733500","volume":"55","author":"I Knani","year":"2018","unstructured":"Knani, I., H. Bouzidi, S. Zrour, N. Bergaoui, M. Hammami, and M. Kerkeni. 2018. Increased serum concentrations of N\u025b-carboxymethyllysine are related to the presence and the severity of rheumatoid arthritis. Annals of clinical biochemistry 55 (4): 430\u2013436.","journal-title":"Annals of clinical biochemistry"},{"key":"1589_CR62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-2094-7-72","volume":"7","author":"Z Sternberg","year":"2010","unstructured":"Sternberg, Z., C. Hennies, D. Sternberg, P. Wang, P. Kinkel, D. Hojnacki, B. Weinstock-Guttmann, and F. Munschauer. 2010. Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis. Journal of Neuroinflammation 7: 72.","journal-title":"Journal of Neuroinflammation"},{"key":"1589_CR63","doi-asserted-by":"crossref","first-page":"9073451","DOI":"10.1155\/2019\/9073451","volume":"2019","author":"S Kinoshita","year":"2019","unstructured":"Kinoshita, S., K. Mera, H. Ichikawa, S. Shimasaki, M. Nagai, Y. Taga, K. Iijima, S. Hattori, Y. Fujiwara, J.I. Shirakawa, and R. Nagai. 2019. N\u03c9 -(carboxymethyl)arginine is one of the dominant advanced glycation end products in glycated collagens and mouse tissues. Oxidative Medicine and Cellular Longevity 2019: 9073451.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1589_CR64","doi-asserted-by":"crossref","unstructured":"Ricard-Blum, S. 2011. The collagen family. Cold Spring Harbor Perspectives in Biology 3 (1): a004978.","DOI":"10.1101\/cshperspect.a004978"},{"issue":"5","key":"1589_CR65","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/jcb.21735","volume":"104","author":"KL Reigle","year":"2008","unstructured":"Reigle, K.L., G. Di Lullo, K.R. Turner, J.A. Last, I. Chervoneva, D.E. Birk, J.L. Funderburgh, E. Elrod, M.W. Germann, C. Surber, R.D. Sanderson, and J.D. San Antonio. 2008. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. Journal of Cellular Biochemistry 104 (5): 1684\u20131698.","journal-title":"Journal of Cellular Biochemistry"},{"key":"1589_CR66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874312901206010064","volume":"6","author":"M Braun","year":"2012","unstructured":"Braun, M., H. Hulejov\u00e1, J. Gatterov\u00e1, M. Filkov\u00e1, A. Pavelkov\u00e1, O. Sl\u00e9glov\u00e1, N. Kasp\u0159\u00edkov\u00e1, J. Vencovsk\u00fd, K. Pavelka, and L. Senolt. 2012. Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis. The Open Rheumatology Journal 6: 64\u201369.","journal-title":"The Open Rheumatology Journal"},{"issue":"6","key":"1589_CR67","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/rheumatology\/36.6.637","volume":"36","author":"M Takahashi","year":"1997","unstructured":"Takahashi, M., M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue. 1997. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. The British Journal of Rheumatology 36 (6): 637\u2013642.","journal-title":"The British Journal of Rheumatology"},{"issue":"1","key":"1589_CR68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/bbrc.1998.8203","volume":"244","author":"T Miyata","year":"1998","unstructured":"Miyata, T., N. Ishiguro, Y. Yasuda, T. Ito, M. Nangaku, H. Iwata, and K. Kurokawa. 1998. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochemical and biophysical research communications 244 (1): 45\u201349.","journal-title":"Biochemical and biophysical research communications"},{"issue":"12","key":"1589_CR69","first-page":"2440","volume":"25","author":"JR Chen","year":"1999","unstructured":"Chen, J.R., M. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue. 1999. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: Relationship with disease activity in rheumatoid arthritis. Journal of Rheumatology 25 (12): 2440\u20132444.","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"1589_CR70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/2230-8210.146863","volume":"19","author":"K Neelofar","year":"2015","unstructured":"Neelofar, K., and J. Ahmad. 2015. Amadori albumin in diabetic nephropathy. Indian Journal of Endocrinology and Metabolism 19 (1): 39\u201346.","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"1589_CR71","first-page":"2","volume":"6","author":"Z Arif","year":"2015","unstructured":"Arif, Z., M.Y. Arfat, J. Ahmad, A. Zaman, S.N. Islam, and M.A. Khan. 2015. Relevance of nitroxidation of albumin in rheumatoid arthritis: A biochemical and clinical study. Journal of Clinical & Cellular Immunology 6: 2.","journal-title":"Journal of Clinical & Cellular Immunology"},{"issue":"4","key":"1589_CR72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5606\/ArchRheumatol.2019.7285","volume":"34","author":"A Tarannum","year":"2019","unstructured":"Tarannum, A., Z. Arif, K. Alam, S. Ahmad, and M. Uddin. 2019. Nitroxidized-albumin advanced glycation end product and rheumatoid arthritis. Archives of Rheumatology 34 (4): 461\u2013475.","journal-title":"Archives of Rheumatology"},{"issue":"4","key":"1589_CR73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/biof.1367","volume":"43","author":"P Baret","year":"2017","unstructured":"Baret, P., F. Le Sage, C. Planesse, O. Meilhac, A. Devin, E. Bourdon, and P. Rondeau. 2017. Glycated human albumin alters mitochondrial respiration in preadipocyte 3T3-L1 cells. BioFactors (Oxford England) 43 (4): 577\u2013592.","journal-title":"BioFactors (Oxford England)"},{"key":"1589_CR74","doi-asserted-by":"crossref","first-page":"6450742","DOI":"10.1155\/2020\/6450742","volume":"2020","author":"J Panezai","year":"2020","unstructured":"Panezai, J., M. Altamash, P.E. Engstr\u04e7m, and A. Larsson. 2020. Association of glycated proteins with inflammatory proteins and periodontal disease parameters. Journal of Diabetes Research 2020: 6450742.","journal-title":"Journal of Diabetes Research"},{"issue":"7","key":"1589_CR75","first-page":"848","volume":"44","author":"NP Babu","year":"2006","unstructured":"Babu, N.P., Z. Bobby, N. Selvaraj, and B.N. Harish. 2006. Increased fructosamine in non-diabetic rheumatoid arthritis patients: Role of lipid peroxides and glutathione. Clinical Chemistry and Laboratory Medicine 44 (7): 848\u2013852.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"3","key":"1589_CR76","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/derm.22028","volume":"4","author":"P Gkogkolou","year":"2012","unstructured":"Gkogkolou, P., and M. B\u00f6hm. 2012. Advanced glycation end products: Key players in skin aging? Dermatoendocrinology 4 (3): 259\u2013270.","journal-title":"Dermatoendocrinology"},{"issue":"2","key":"1589_CR77","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1042\/BJ20061232","volume":"399","author":"VM Monnier","year":"2006","unstructured":"Monnier, V.M. 2006. The fructosamine 3-kinase knockout mouse: A tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging. Biochemical Journal 399 (2): e11\u2013e13.","journal-title":"Biochemical Journal"},{"key":"1589_CR78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13075-018-1636-6","volume":"20","author":"C Legrand","year":"2018","unstructured":"Legrand, C., U. Ahmed, A. Anwar, K. Rajpoot, S. Pasha, C. Lambert, R.K. Davidson, I.M. Clark, P.J. Thornalley, Y. Henrotin, and N. Rabbani. 2018. Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research & Therapy 20: 131.","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"1589_CR79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/cclm-2013-0174","volume":"52","author":"VM Monnier","year":"2014","unstructured":"Monnier, V.M., W. Sun, D.R. Sell, X. Fan, I. Nemet, and S. Genuth. 2014. Glucosepane: A poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clinical Chemistry and Laboratory Medicine 52 (1): 21\u201332.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"1","key":"1589_CR80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2337\/db14-0215","volume":"64","author":"S Genuth","year":"2015","unstructured":"Genuth, S., W. Sun, P. Cleary, X. Gao, D.R. Sell, J. Lachin, and V.M. Monnier. 2015. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 64 (1): 266\u2013278.","journal-title":"Diabetes"},{"issue":"1","key":"1589_CR81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2249.2000.01188.x","volume":"120","author":"AW Tai","year":"2000","unstructured":"Tai, A.W., and M.M. Newkirk. 2000. An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA). Clinical and Experimental Immunology 120 (1): 188\u2013193.","journal-title":"Clinical and Experimental Immunology"},{"issue":"2","key":"1589_CR82","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar622","volume":"5","author":"MM Newkirk","year":"2003","unstructured":"Newkirk, M.M., R. Goldbach-Mansky, J. Lee, J. Hoxworth, A. McCoy, C. Yarboro, J. Klippel, and H.S. El-Gabalawy. 2003. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Research & Therapy 5 (2): R82\u2013R90.","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"1589_CR83","first-page":"1129","volume":"44","author":"MM Newkirk","year":"1998","unstructured":"Newkirk, M.M., K. LePage, T. Niwa, and L. Rubin. 1998. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). Cellular and molecular biology 44 (7): 1129\u20131138.","journal-title":"Cellular and molecular biology"},{"key":"1589_CR84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2017.02.030","volume":"177","author":"K Byun","year":"2017","unstructured":"Byun, K., Y. Yoo, M. Son, J. Lee, G.B. Jeong, Y.M. Park, G.H. Salekdeh, and B. Lee. 2017. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacology & Therapeutics 177: 44\u201355.","journal-title":"Pharmacology & Therapeutics"},{"issue":"30","key":"1589_CR85","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/138161208786404137","volume":"14","author":"G Yamin","year":"2008","unstructured":"Yamin, G., K. Ono, M. Inayathullah, and D.B. Teplow. 2008. Amyloid beta-protein assembly as a therapeutic target of Alzheimer\u2019s disease. Current Pharmaceutical Design 14 (30): 3231\u20133246.","journal-title":"Current Pharmaceutical Design"},{"key":"1589_CR86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O\u2019Brien, R.J., and P.C. Wong. 2011. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annual Review of Neuroscience 34: 185\u2013204.","journal-title":"Annual Review of Neuroscience"},{"issue":"79","key":"1589_CR87","first-page":"379","volume":"14","author":"G Ferraccioli","year":"2012","unstructured":"Ferraccioli, G., A. Carbonella, E. Gremese, and S. Alivernini. 2012. Rheumatoid arthritis and Alzheimer\u2019s disease: Genetic and epigenetic links in inflammatory regulation. Discovery Medicine 14 (79): 379\u2013388.","journal-title":"Discovery Medicine"},{"key":"1589_CR88","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3389\/fimmu.2019.02980","volume":"10","author":"YM Huang","year":"2020","unstructured":"Huang, Y.M., X.Z. Hong, J. Shen, L.J. Geng, Y.H. Pan, W. Ling, and H.L. Zhao. 2020. Amyloids in site-specific autoimmune reactions and inflammatory responses. Frontiers in Immunology 10: 2980.","journal-title":"Frontiers in Immunology"},{"issue":"1\u20132","key":"1589_CR89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","volume":"1799","author":"D Tang","year":"2010","unstructured":"Tang, D., R. Kang, H.J. Zeh, and M.T. Lotze. 2010. High-mobility group box 1 and cancer. Biochimica et Biophysica Acta 1799 (1\u20132): 131\u2013140.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1589_CR90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson, U., and K.J. Tracey. 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annual Review of Immunology 29: 139\u2013162.","journal-title":"Annual Review of Immunology"},{"issue":"17","key":"1589_CR91","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1089\/ars.2015.6299","volume":"23","author":"DJ Weber","year":"2015","unstructured":"Weber, D.J., Y.M. Allette, D.S. Wilkes, and F.A. White. 2015. The HMGB1-RAGE inflammatory pathway: Implications for brain injury-induced pulmonary dysfunction. Antioxidants & Redox Signaling 23 (17): 1316\u20131328.","journal-title":"Antioxidants & Redox Signaling"},{"key":"1589_CR92","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.12659\/MSM.895689","volume":"22","author":"XH Sun","year":"2016","unstructured":"Sun, X.H., Y. Liu, Y. Han, and J. Wang. 2016. Expression and significance of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis. Medical Science Monitor 22: 2105\u20132112.","journal-title":"Medical Science Monitor"},{"issue":"1","key":"1589_CR93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40001-020-00406-5","volume":"25","author":"B Qian","year":"2020","unstructured":"Qian, B., H. Huang, M. Cheng, T. Qin, T. Chen, and J. Zhao. 2020. Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury. European Journal of Medical Research 25 (1): 8.","journal-title":"European Journal of Medical Research"},{"issue":"7","key":"1589_CR94","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1089\/ars.2010.3356","volume":"14","author":"D Tang","year":"2011","unstructured":"Tang, D., R. Kang, H.J. Zeh, and M.T. Lotze. 2011. High-mobility group box 1 oxidative stress and disease. Antioxidants & redox signaling 14 (7): 1315\u20131335.","journal-title":"Antioxidants & redox signaling"},{"issue":"10","key":"1589_CR95","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/jir.2008.0104","volume":"29","author":"XM Zhu","year":"2009","unstructured":"Zhu, X.M., Y.M. Yao, H.P. Liang, S. Xu, N. Dong, Y. Yu, and Z.Y. Sheng. 2009. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. Journal of interferon & cytokine research 29 (10): 677\u2013686.","journal-title":"Journal of interferon & cytokine research"},{"issue":"4","key":"1589_CR96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.2000.00015.x","volume":"99","author":"S Yoshino","year":"2000","unstructured":"Yoshino, S., E. Sasatomi, and M. Ohsawa. 2000. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology 99 (4): 607\u2013614.","journal-title":"Immunology"},{"key":"1589_CR97","doi-asserted-by":"crossref","unstructured":"Fang, W., D. Bi, R. Zheng, N. Cai, H. Xu, R. Zhou, J. Lu, M. Wan, and X. Xu. 2017. Identification and activation of TLR4-mediated signalling pathways by alginate-derived guluronate oligosaccharide in RAW264.7 macrophages. Scientific Reports 7 (1): 1663.","DOI":"10.1038\/s41598-017-01868-0"},{"issue":"4","key":"1589_CR98","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar3450","volume":"13","author":"H Wahamaa","year":"2011","unstructured":"Wahamaa, H., H. Schierbeck, H.S. Hreggvidsdottir, K. Palmblad, A.C. Aveberger, U. Andersson, and H.E. Harris. 2011. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis research & therapy 13 (4): R136.","journal-title":"Arthritis research & therapy"},{"key":"1589_CR99","doi-asserted-by":"crossref","unstructured":"He, Z.W., Y.H. Qin, Z.W. Wang, Y. Chen, Q. Shen, and S.M. Dai. 2013. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-\u03baB signaling pathways. Mediators of Inflammation 2013: 596716.","DOI":"10.1155\/2013\/596716"},{"issue":"4","key":"1589_CR100","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/ijms21041402","volume":"21","author":"M Bednarczyk","year":"2020","unstructured":"Bednarczyk, M., H. Stege, S. Grabbe, and M. Bros. 2020. \u03b22 Integrins-multi-functional leukocyte receptors in health and disease. International Journal of Molecular Sciences 21 (4): 1402.","journal-title":"International Journal of Molecular Sciences"},{"key":"1589_CR101","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3389\/fimmu.2017.01866","volume":"8","author":"L Schittenhelm","year":"2017","unstructured":"Schittenhelm, L., C.M. Hilkens, and V.L. Morrison. 2017. \u03b22 integrins as regulators of dendritic cell monocyte and macrophage function. Frontiers in Immunology 8: 1866.","journal-title":"Frontiers in Immunology"},{"key":"1589_CR102","doi-asserted-by":"crossref","first-page":"42874","DOI":"10.1038\/srep42874","volume":"7","author":"O Kassaar","year":"2017","unstructured":"Kassaar, O., M. Pereira Morais, S. Xu, E.L. Adam, R.C. Chamberlain, B. Jenkins, T.D. James, P.T. Francis, S. Ward, R.J. Williams, and J. van den Elsen. 2017. Macrophage migration inhibitory factor is subjected to glucose modification and oxidation in Alzheimer\u2019s disease. Scientific Reports 7: 42874.","journal-title":"Scientific Reports"},{"issue":"1","key":"1589_CR103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","volume":"13","author":"R Donato","year":"2013","unstructured":"Donato, R., B.R. Cannon, G. Sorci, F. Riuzzi, K. Hsu, D.J. Weber, and C.L. Geczy. 2013. Functions of S100 proteins. Current Molecular Medicine 13 (1): 24\u201357.","journal-title":"Current Molecular Medicine"},{"issue":"3","key":"1589_CR104","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3390\/ijms13032893","volume":"13","author":"T Vogl","year":"2012","unstructured":"Vogl, T., A.L. Gharibyan, and L.A. Morozova-Roche. 2012. Pro-inflammatory S100A8 and S100A9 proteins: Self-assembly into multifunctional native and amyloid complexes. International Journal of Molecular Sciences 13 (3): 2893\u20132917.","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"1589_CR105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/14728222.2017.1330411","volume":"21","author":"J Austermann","year":"2017","unstructured":"Austermann, J., S. Zenker, and J. Roth. 2017. S100-alarmins: Potential therapeutic targets for arthritis. Expert Opinion on Therapeutic Targets 21 (7): 738\u2013750.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"4","key":"1589_CR106","first-page":"126","volume":"7","author":"Q Wang","year":"2019","unstructured":"Wang, Q., W. Chen, and J. Lin. 2019. The role of calprotectin in rheumatoid arthritis. Journal of Translational Medicine 7 (4): 126\u2013131.","journal-title":"Journal of Translational Medicine"},{"issue":"2","key":"1589_CR107","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar2645","volume":"11","author":"YS Chen","year":"2009","unstructured":"Chen, Y.S., W. Yan, C.L. Geczy, M.A. Brown, and R. Thomas. 2009. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis research & therapy 11 (2): R39.","journal-title":"Arthritis research & therapy"},{"issue":"9","key":"1589_CR108","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1074\/jbc.M110.169342","volume":"286","author":"R Bianchi","year":"2011","unstructured":"Bianchi, R., E. Kastrisianaki, I. Giambanco, and R. Donato. 2011. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. The Journal of biological chemistry 286 (9): 7214\u20137226.","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"1589_CR109","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/s41598-021-85561-3","volume":"11","author":"A Navratilova","year":"2021","unstructured":"Navratilova, A., V. Becvar, J. Baloun, D. Damgaard, C.H. Nielsen, D. Veigl, K. Pavelka, J. Vencovsky, L. \u0160enolt, and L. Andres Cerezo. 2021. S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils. Scientific reports 11 (1): 6063.","journal-title":"Scientific reports"},{"issue":"20","key":"1589_CR110","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/bi500046t","volume":"53","author":"J Xue","year":"2014","unstructured":"Xue, J., R. Ray, D. Singer, D. B\u00f6hme, D.S. Burz, V. Rai, R. Hoffmann, and A. Shekhtman. 2014. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry 53 (20): 3327\u20133335.","journal-title":"Biochemistry"},{"issue":"Pt 6","key":"1589_CR111","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1042\/bst0311400","volume":"31","author":"M Bourajjaj","year":"2003","unstructured":"Bourajjaj, M., C.D. Stehouwer, V.W. van Hinsbergh, and C.G. Schalkwijk. 2003. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochemical Society Transactions 31 (Pt 6): 1400\u20131402.","journal-title":"Biochemical Society Transactions"},{"key":"1589_CR112","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3389\/fimmu.2019.00855","volume":"10","author":"S Wetzels","year":"2019","unstructured":"Wetzels, S., T. Vanmierlo, J.L.J.M. Scheijen, J. van Horssen, S. Amor, V. Somers, C.G. Schalkwijk, J.J.A. Hendriks, and K. Wouters. 2019. Methylglyoxal-derived advanced glycation endproducts accumulate in multiple sclerosis lesions. Frontiers in Immunology 10: 855.","journal-title":"Frontiers in Immunology"},{"key":"1589_CR113","doi-asserted-by":"crossref","unstructured":"Lugo-Huitr\u00f3n, R., P. Ugalde Mu\u00f1iz, B. Pineda, J. Pedraza-Chaverr\u00ed, C. R\u00edos, and V. P\u00e9rez-de la Cruz. 2013. Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxidative Medicine and Cellular Longevity 2013: 104024.","DOI":"10.1155\/2013\/104024"},{"key":"1589_CR114","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fphar.2019.00452","volume":"10","author":"Y Bansal","year":"2019","unstructured":"Bansal, Y., R. Singh, I. Parhar, A. Kuhad, and T. Soga. 2019. Quinolinic acid and nuclear factor erythroid 2-related factor 2 in depression: Role in neuroprogression. Frontiers in Pharmacology 10: 452.","journal-title":"Frontiers in Pharmacology"},{"key":"1589_CR115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","volume":"11","author":"YS Huang","year":"2020","unstructured":"Huang, Y.S., J. Ogbechi, F.I. Clanchy, R.O. Williams, and T.W. Stone. 2020. IDO and kynurenine metabolites in peripheral and CNS disorders. Frontiers in Immunology 11: 388.","journal-title":"Frontiers in Immunology"},{"issue":"37","key":"1589_CR116","doi-asserted-by":"crossref","first-page":"14312","DOI":"10.1074\/jbc.RA118.004450","volume":"293","author":"F Salgado-Polo","year":"2018","unstructured":"Salgado-Polo, F., A. Fish, M.T. Matsoukas, T. Heidebrecht, W.J. Keune, and A. Perrakis. 2018. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency. Journal of Biological Chemistry 293 (37): 14312\u201314327.","journal-title":"Journal of Biological Chemistry"},{"key":"1589_CR117","doi-asserted-by":"crossref","unstructured":"Miyabe, C., Y. Miyabe, J. Nagai, N.N. Miura, N. Ohno, J. Chun, R. Tsuboi, H. Ueda, M. Miyasaka, N. Miyasaka, and T. Nanki. 2019. Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis. Arthritis Research & Therapy 21 (1): 191.","DOI":"10.1186\/s13075-019-1973-0"},{"key":"1589_CR118","doi-asserted-by":"crossref","unstructured":"Miyabe, Y., C. Miyabe, Y. Iwai, A. Takayasu, S. Fukuda, W. Yokoyama, J. Nagai, M. Jona, Y. Tokuhara, R. Ohkawa, H.M. Albers, H. Ovaa, J. Aoki, J. Chun, Y. Yatomi, H. Ueda, M. Miyasaka, N. Miyasaka, and T. Nanki T. 2013. Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis & Rheumatology 65 (8): 2037\u20132047.","DOI":"10.1002\/art.37991"},{"issue":"13","key":"1589_CR119","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20120873","volume":"209","author":"V Rai","year":"2012","unstructured":"Rai, V., F. Tour\u00e9, S. Chitayat, R. Pei, F. Song, Q. Li, J. Zhang, R. Rosario, R. Ramasamy, W.J. Chazin, and A.M. Schmidt. 2012. Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. Journal of Experimental Medicine 209 (13): 2339\u20132350.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"1589_CR120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/excr.1996.0308","volume":"228","author":"EW Howard","year":"1996","unstructured":"Howard, E.W., R. Benton, J. Ahern-Moore, and J.J. Tomasek. 1996. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation. Experimental cell research 228 (1): 132\u2013137.","journal-title":"Experimental cell research"},{"key":"1589_CR121","unstructured":"Tatsuro, E., K. Kohei, Y. Takumi, F. Mami, G. Katsumasa, and H. Tatsuya. 2021. The Effect of Glycation Stress on Skeletal Muscle. Intechopen."},{"issue":"2","key":"1589_CR122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3164\/jcbn.2007014","volume":"41","author":"AK Ahmed","year":"2007","unstructured":"Ahmed, A.K., S. Muniandy, and I. Ismail. 2007. Role of N-(carboxymethyl) lysine in the development of ischemic heart disease in type 2 diabetes mellitus. Journal of clinical biochemistry and nutrition 41 (2): 97\u2013105.","journal-title":"Journal of clinical biochemistry and nutrition"},{"key":"1589_CR123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2474-11-83","volume":"11","author":"R Vyt\u00e1\u0161ek","year":"2010","unstructured":"Vyt\u00e1\u0161ek, R., L. Sedova, and V. Vil\u00edm. 2010. Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis. BMC Musculoskeletal Disorder 11: 83.","journal-title":"BMC Musculoskeletal Disorder"},{"issue":"6","key":"1589_CR124","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","volume":"6","author":"CA Hitchon","year":"2004","unstructured":"Hitchon, C.A., and H.S. El-Gabalawy. 2004. Oxidation in rheumatoid arthritis. Arthritis Research & Therapy 6 (6): 265\u2013278.","journal-title":"Arthritis Research & Therapy"},{"key":"1589_CR125","doi-asserted-by":"crossref","unstructured":"Chimenti, M.S., P. Triggianese, P. Conigliaro, E. Candi, G. Melino, and R. Perricone. 2015. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death & Disease 6 (9): e1887.","DOI":"10.1038\/cddis.2015.246"},{"issue":"3","key":"1589_CR126","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1194\/jlr.M200370-JLR200","volume":"44","author":"G Virella","year":"2003","unstructured":"Virella, G., S.R. Thorpe, N.L. Alderson, E.M. Stephan, D. Atchley, F. Wagner, M.F. Lopes-Virella, and DCCT\/EDIC Research Group. 2003. Autoimmune response to advanced glycosylation end-products of human LDL. Journal of Lipid Research 44 (3): 487\u2013493.","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"1589_CR127","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","volume":"32","author":"V Srikanth","year":"2011","unstructured":"Srikanth, V., A. Maczurek, T. Phan, M. Steele, B. Westcott, D. Juskiw, and G. M\u00fcnch. 2011. Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease. Neurobiology of Aging 32 (5): 763\u2013777.","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"1589_CR128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1753-0407.12475","volume":"9","author":"SI Yamagishi","year":"2017","unstructured":"Yamagishi, S.I., N. Nakamura, and T. Matsui. 2017. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory. Journal of Diabetes 9 (2): 141\u2013148.","journal-title":"Journal of Diabetes"},{"issue":"1","key":"1589_CR129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11926-003-0081-x","volume":"5","author":"DM Saudek","year":"2005","unstructured":"Saudek, D.M., and J. Kay. 2005. Advanced glycation endproducts and osteoarthritis. Current Rheumatology Reports 5 (1): 33\u201340.","journal-title":"Current Rheumatology Reports"},{"issue":"23","key":"1589_CR130","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1021\/bi7003735","volume":"46","author":"BM Dattilo","year":"2007","unstructured":"Dattilo, B.M., G. Fritz, E. Leclerc, C.W. Kooi, C.W. Heizmann, and W.J. Chazin. 2007. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46 (23): 6957\u20136970.","journal-title":"Biochemistry"},{"issue":"12","key":"1589_CR131","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","volume":"50","author":"A Bierhaus","year":"2001","unstructured":"Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P.M. Humpert, J. Chen, M. Hon, T. Luther, T. Henle, I. Kl\u00f6ting, M. Morcos, M. Hofmann, H. Tritschler, B. Weigle, M. Kasper, M. Smith, G. Perry, A.M. Schmidt, D.M. Stern, H.U. H\u00e4ring, E. Schleicher, and P.P. Nawroth. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50 (12): 2792\u20132808.","journal-title":"Diabetes"},{"issue":"3","key":"1589_CR132","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1189\/jlb.0409230","volume":"86","author":"R Ramasamy","year":"2009","unstructured":"Ramasamy, R., S.F. Yan, and A.M. Schmidt. 2009. RAGE: Therapeutic target and biomarker of the inflammatory response\u2013the evidence mounts. Journal of Leukocyte Biology 86 (3): 505\u2013512.","journal-title":"Journal of Leukocyte Biology"},{"issue":"17","key":"1589_CR133","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","volume":"60","author":"S Bongarzone","year":"2017","unstructured":"Bongarzone, S., V. Savickas, F. Luzi, and A.D. Gee. 2017. Targeting the receptor for advanced glycation endproducts (RAGE): A medicinal chemistry perspective. Journal of Medicinal Chemistry 60 (17): 7213\u20137232.","journal-title":"Journal of Medicinal Chemistry"},{"key":"1589_CR134","doi-asserted-by":"crossref","unstructured":"Wu, C., X. Du, L. Tang, J. Wu, W. Zhao, X. Guo, D. Liu, W. Liu, H. Helmby, G. Chen, and Z.\u00a0Wang.\u00a02020. Schistosoma japonicum SjE16.7 protein promotes tumor development via the receptor for advanced glycation end products (RAGE). Frontiers in Immunology 11: 1767.","DOI":"10.3389\/fimmu.2020.01767"},{"issue":"4","key":"1589_CR135","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar3398","volume":"13","author":"YJ Heo","year":"2011","unstructured":"Heo, Y.J., H.J. Oh, Y.O. Jung, M.L. Cho, S.Y. Lee, J.G. Yu, M.K. Park, H.R. Kim, S.H. Lee, S.H. Park, and H.Y. Kim. 2011. The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1. Arthritis Research & Therapy 13 (4): R113.","journal-title":"Arthritis Research & Therapy"},{"key":"1589_CR136","doi-asserted-by":"crossref","unstructured":"Bednarska, K., and I. Fecka.\u00a0\u00a02021. Potential of Vasoprotectives to Inhibit Non-Enzymatic Protein Glycation, and Reactive Carbonyl and Oxygen Species Uptake. International Journal of Molecular Sciences\u00a022 :10026","DOI":"10.3390\/ijms221810026"},{"issue":"2","key":"1589_CR137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40495-017-0081-6","volume":"3","author":"SS Davies","year":"2017","unstructured":"Davies, S.S., and L.S. Zhang. 2017. Reactive carbonyl species scavengers-novel therapeutic approaches for chronic diseases. Current pharmacology reports 3 (2): 51\u201367.","journal-title":"Current pharmacology reports"},{"key":"1589_CR138","doi-asserted-by":"crossref","unstructured":"Nenna, A., F. Nappi, S.S. Avtaar Singh, F.W. Sutherland, F. Di Domenico, M. Chello, and C. Spadaccio. 2015. Pharmacologic approaches against advanced glycation end products (AGEs) in diabetic cardiovascular disease. Research in cardiovascular medicine 4 (2): e26949.","DOI":"10.4103\/2251-9572.218778"},{"issue":"3","key":"1589_CR139","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","volume":"25","author":"SJ Zieman","year":"2007","unstructured":"Zieman, S.J., V. Melenovsky, L. Clattenburg, M.C. Corretti, A. Capriotti, G. Gerstenblith, and D.A. Kass. 2007. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. Journal of hypertension 25 (3): 577\u2013583.","journal-title":"Journal of hypertension"},{"issue":"6","key":"1589_CR140","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/dc05-2096","volume":"29","author":"AG Huebschmann","year":"2006","unstructured":"Huebschmann, A.G., J.G. Regensteiner, H. Vlassara, and J.E. Reusch. 2006. Diabetes and advanced glycoxidation end products. Diabetes Care 29 (6): 1420\u20131432.","journal-title":"Diabetes Care"},{"issue":"14","key":"1589_CR141","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1074\/jbc.M600418200","volume":"281","author":"E Berrone","year":"2006","unstructured":"Berrone, E., E. Beltramo, C. Solimine, A.U. Ape, and M. Porta. 2006. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. The Journal of biological chemistry 281 (14): 9307\u20139313.","journal-title":"The Journal of biological chemistry"},{"issue":"9","key":"1589_CR142","first-page":"344","volume":"8","author":"R Ramis","year":"2019","unstructured":"Ramis, R., J. Ortega-Castro, C. Caballero, R. Casasnovas, A. Cerrillo, B. Vilanova, M. Adrover, and J. Frau. 2019. How does pyridoxamine inhibit the formation of advanced glycation end products? The role of its primary antioxidant activity. Antioxidants (Basel Switzerland) 8 (9): 344.","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"1589_CR143","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnut.2019.00048","volume":"6","author":"K Yoshii","year":"2019","unstructured":"Yoshii, K., K. Hosomi, and K, Sawane, and J. Kunisawa. 2019. Metabolism of dietary and microbial vitamin b family in the regulation of host immunity. Frontiers in nutrition 6: 48.","journal-title":"Frontiers in nutrition"},{"issue":"1","key":"1589_CR144","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1756-185X.2011.01679.x","volume":"15","author":"A Syngle","year":"2012","unstructured":"Syngle, A., K. Vohra, N. Garg, L. Kaur, and P. Chand. 2012. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis. International journal of rheumatic diseases 15 (1): 45\u201355.","journal-title":"International journal of rheumatic diseases"},{"issue":"52","key":"1589_CR145","doi-asserted-by":"crossref","first-page":"48967","DOI":"10.1074\/jbc.M108196200","volume":"276","author":"DL Price","year":"2001","unstructured":"Price, D.L., P.M. Rhett, S.R. Thorpe, and J.W. Baynes. 2001. Chelating activity of advanced glycation end-product inhibitors. The Journal of biological chemistry 276 (52): 48967\u201348972.","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"1589_CR146","doi-asserted-by":"crossref","first-page":"R817","DOI":"10.1186\/ar1749","volume":"7","author":"R Pullerits","year":"2005","unstructured":"Pullerits, R., M. Bokarewa, L. Dahlberg, and A. Tarkowski. 2005. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis research & therapy 7 (4): R817\u2013R824.","journal-title":"Arthritis research & therapy"},{"key":"1589_CR147","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12986-018-0306-7","volume":"15","author":"JH Chen","year":"2018","unstructured":"Chen, J.H., X. Lin, C. Bu, and X. Zhang. 2018. Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies. Nutrition & metabolism 15: 72.","journal-title":"Nutrition & metabolism"},{"key":"1589_CR148","doi-asserted-by":"crossref","first-page":"205951311667682","DOI":"10.1177\/2059513116676828","volume":"2","author":"L Van Putte","year":"2016","unstructured":"Van Putte, L., S. De Schrijver, and P. Moortgat. 2016. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: A systematic review. Scars burns & healing 2: 2059513116676828.","journal-title":"Scars burns & healing"},{"key":"1589_CR149","doi-asserted-by":"crossref","unstructured":"Mirmiranpour, H., S.Z. Bathaie, S. Khaghani, M. Nakhjavani, and A. Kebriaeezadeh. 2021. L-lysine supplementation improved glycemic control, decreased protein glycation, and insulin resistance in type 2 diabetic patients. International Journal of Diabetes in Developing Countries.","DOI":"10.1007\/s13410-021-00931-x"},{"issue":"1","key":"1589_CR150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13075-019-1909-8","volume":"21","author":"G Mouterde","year":"2019","unstructured":"Mouterde, G., N. Rincheval, C. Lukas, C. Daien, A. Saraux, P. Dieud\u00e9, J. Morel, and B. Combe. 2019. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort. Arthritis Research & Therapy 21 (1): 140.","journal-title":"Arthritis Research & Therapy"},{"key":"1589_CR151","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fcimb.2012.00168","volume":"2","author":"N Jounai","year":"2013","unstructured":"Jounai, N., K. Kobiyama, F. Takeshita, and K.J. Ishii. 2013. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Frontiers in Cellular and Infection Microbiology 2: 168.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"1589_CR152","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2016.10.012","volume":"254","author":"LC de Vos","year":"2016","unstructured":"de Vos, L.C., J.D. Lefrandt, R.P. Dullaart, C.J. Zeebregts, and A.J. Smit. 2016. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis 254: 291\u2013299.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1589_CR153","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1183\/09031936.00135312","volume":"43","author":"P Gopal","year":"2014","unstructured":"Gopal, P., N.L. Reynaert, J.L. Scheijen, L. Engelen, C.G. Schalkwijk, F.M. Franssen, E.F. Wouters, and E.P. Rutten. 2014. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD. The European respiratory journal 43 (2): 430\u2013438.","journal-title":"The European respiratory journal"},{"issue":"6","key":"1589_CR154","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2217\/bmm-2018-0448","volume":"13","author":"AM B\u0103b\u0163an","year":"2019","unstructured":"B\u0103b\u0163an, A.M., A. Ilea, B.A. Bo\u015fca, M. Cri\u015fan, N.B. Petrescu, M. Collino, R.M. Sainz, J.Q. Gerlach, and R.S. C\u00e2mpian. 2019. Advanced glycation end products as biomarkers in systemic diseases: Premises and perspectives of salivary advanced glycation end products. Biomarkers in medicine 13 (6): 479\u2013495.","journal-title":"Biomarkers in medicine"},{"issue":"17","key":"1589_CR155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","volume":"35","author":"NM Hanssen","year":"2014","unstructured":"Hanssen, N.M., K. Wouters, M.S. Huijberts, M.J. Gijbels, J.C. Sluimer, J.L. Scheijen, S. Heeneman, E.A. Biessen, M.J. Daemen, M. Brownlee, D.P. de Kleijn, C.D. Stehouwer, G. Pasterkamp, and C.G. Schalkwijk. 2014. Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. European heart journal 35 (17): 1137\u20131146.","journal-title":"European heart journal"},{"key":"1589_CR156","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.freeradbiomed.2019.06.023","volume":"144","author":"A Martinez Fernandez","year":"2019","unstructured":"Martinez Fernandez, A., L. Regazzoni, M. Bioschi, E. Gianazza, P. Agostoni, G. Aldini, and C. Banfi. 2019. Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes. Free radical biology & medicine 144: 245\u2013255.","journal-title":"Free radical biology & medicine"},{"issue":"1","key":"1589_CR157","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbspin.2016.01.011","volume":"84","author":"JS Park","year":"2017","unstructured":"Park, J.S., J. Song, Y.B. Park, S.K. Lee, and S.W. Lee. 2017. Glycated albumin increases with disease activity in rheumatoid factor positive rheumatoid arthritis patients with normal fasting glucose and HbA1c. Joint, Bone, Spine 84 (1): 115\u2013118.","journal-title":"Joint, Bone, Spine"},{"issue":"8","key":"1589_CR158","first-page":"1071","volume":"46","author":"M Ben-Hadj-Mohamed","year":"2017","unstructured":"Ben-Hadj-Mohamed, M., S. Khelil, M. Ben Dbibis, L. Khlifi, H. Chahed, S. Ferchichi, E. Bouajina, and A. Miled. 2017. Hepatic proteins and inflammatory markers in rheumatoid arthritis patients. Iranian Journal of Public Health 46 (8): 1071\u20131078.","journal-title":"Iranian Journal of Public Health"},{"issue":"8","key":"1589_CR159","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","volume":"75","author":"B Bergum","year":"2016","unstructured":"Bergum, B., C. Koro, N. Delaleu, M. Solheim, A. Hellvard, V. Binder, R. Jonsson, V. Valim, D.S. Hammenfors, M.V. Jonsson, and P. Mydel. 2016. Antibodies against carbamylated proteins are present in primary Sj\u00f6gren\u2019s syndrome and are associated with disease severity. Annals of the Rheumatic Diseases 75 (8): 1494\u20131500.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"1589_CR160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-006-0197-4","volume":"49","author":"EJ Dunn","year":"2006","unstructured":"Dunn, E.J., H. Philippou, R.A. Ari\u00ebns, and P.J. Grant. 2006. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia 49 (5): 1071\u20131080.","journal-title":"Diabetologia"},{"issue":"2","key":"1589_CR161","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1044-0305(99)00134-8","volume":"11","author":"A Lapolla","year":"2000","unstructured":"Lapolla, A., D. Fedele, M. Garbeglio, L. Martano, R. Tonani, R. Seraglia, D. Favretto, M.A. Fedrigo, and P. Traldi. 2000. Matrix-assisted laser desorption\/ionization mass spectrometry, enzymatic digestion and molecular modeling in the study of nonenzymatic glycation of IgG. Journal of the American Society for Mass Spectrometry 11 (2): 153\u2013159.","journal-title":"Journal of the American Society for Mass Spectrometry"},{"issue":"2","key":"1589_CR162","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph11020038","volume":"11","author":"S Spiller","year":"2018","unstructured":"Spiller, S., Y. Li, M. Bl\u00fcher, L. Welch, and R. Hoffmann. 2018. Diagnostic accuracy of protein glycation sites in long-term controlled patients with type 2 diabetes mellitus and their prognostic potential for early diagnosis. Pharmaceuticals (Basel) 11 (2): 38.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"1589_CR163","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","volume":"30","author":"E Nob\u00e9court","year":"2010","unstructured":"Nob\u00e9court, E., F. Tabet, G. Lambert, R. Puranik, S. Bao, L. Yan, M.J. Davies, B.E. Brown, A.J. Jenkins, G.J. Dusting, D.J. Bonnet, L.K. Curtiss, P.J. Barter, and K.A. Rye. 2010. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arteriosclerosis thrombosis and vascular biology 30 (4): 766\u2013772.","journal-title":"Arteriosclerosis thrombosis and vascular biology"},{"key":"1589_CR164","doi-asserted-by":"crossref","unstructured":"Sabitha, D., E. Dawson, S. Tiwari, P. Swetha, S.M. Naushad, K.S. Baba, S. Sai, I.K. Mohan, and G.U. Rani. 2020. Study of glycation of transferrin and its effect on biomarkers of iron status in uncontrolled diabetes mellitus patients. Journal of Clinical & Diagnostic Research 14 (8): BC06-BC09.","DOI":"10.7860\/JCDR\/2020\/44506.13909"},{"key":"1589_CR165","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3389\/fimmu.2019.02099","volume":"10","author":"S Kumar","year":"2019","unstructured":"Kumar, S., and M. Dikshit. 2019. Metabolic insight of neutrophils in health and disease. Frontiers in immunology 10: 2099.","journal-title":"Frontiers in immunology"},{"key":"1589_CR166","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s10067-021-05771-y","volume":"40","author":"SR Najafizadeh","year":"2021","unstructured":"Najafizadeh, S.R., K. Amiri, M. Moghaddassi, S. Khanmohammadi, H. Mirmiranpour, and M. Nakhjavani. 2021. Advanced glycation end products advanced oxidation protein products and ferric reducing ability of plasma in patients with rheumatoid arthritis: A focus on activity scores. Clinical Rheumatology 40: 4019\u20134026. https:\/\/doi.org\/10.1007\/s10067-021-05771-y.","journal-title":"Clinical Rheumatology"},{"issue":"44","key":"1589_CR167","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.2174\/1381612825666190130145549","volume":"24","author":"D Schroter","year":"2018","unstructured":"Schroter, D., and A. Hohn. 2018. Role of advanced glycation end products in carcinogenesis and their therapeutic implications. Current Pharmaceutical Design 24 (44): 5245\u20135251.","journal-title":"Current Pharmaceutical Design"},{"key":"1589_CR168","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijbiomac.2018.09.107","volume":"122","author":"Y Li","year":"2019","unstructured":"Li, Y., M.S. Khan, F. Akhter, F.M. Husain, S. Ahmad, and L. Chen. 2019. The non-enzymatic glycation of LDL proteins results in biochemical alterations - a correlation study of Apo B100-AGE with obesity and rheumatoid arthritis. International Journal of Biological Macromolecules 122: 195\u2013200.","journal-title":"International Journal of Biological Macromolecules"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01589-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-021-01589-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01589-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:29:17Z","timestamp":1726136957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-021-01589-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1007\/s10753-021-01589-7","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}